studsvik_logo_cmyk1Press Release

Studsvik divests its operations in personal dosimetry services to NYSE listed Landauer, Inc. The sale further strengthens Studsvik’s focus on its main business areas. The sale generates a capital gain of SEK 6.5 million.

Read it all..